Progenesis QI Software Acquisition

The FDA is seeking a commercial perpetual software license for Progenesis QI Software. The software should support vendor-independent LC-MS raw data import, automated end-to-end data processing workflow, and provide advanced peak picking algorithms. The contractor shall deliver the software, activation credentials, and user documentation within 90 calendar days of award. The contract will be a firm-fixed-price order, and the government intends to award the order without clarification or discussions with vendors. • The software should meet specific technical requirements, including support for vendor-independent LC-MS raw data import and automated end-to-end data processing workflow. • The contractor shall provide user documentation and support for the software. • The government will evaluate quotes for technical acceptability and price, and will award the order based on the lowest evaluated price quote meeting the acceptability standards. • The contract will include clauses related to accessibility, security, and other federal requirements. • The contractor shall comply with all applicable federal laws and regulations, including those related to accessibility and security.